All Stories

  1. Working memory training efficacy in COPD: the randomised double-blind placebo-controlled Cogtrain trial
  2. Network Analysis of Genome-Wide Association Studies for Chronic Obstructive Pulmonary Disease in the Context of Biological Pathways
  3. Safety and Tolerability of Targeted Medical Nutrition for Cachexia in Non-Small-Cell Lung Cancer: A Randomized, Double-Blind, Controlled Pilot Trial
  4. Cross-sectional and longitudinal assessment of muscle from regular chest computed tomography scans: L1 and pectoralis muscle compared to L3 as reference in non-small cell lung cancer
  5. Coordinated regulation of skeletal muscle mass and metabolic plasticity during recovery from disuse
  6. Cognitive impairment in chronic obstructive pulmonary disease: disease burden, determinants and possible future interventions
  7. Increased Myogenic and Protein Turnover Signaling in Skeletal Muscle of Chronic Obstructive Pulmonary Disease Patients With Sarcopenia
  8. The development and validation of the Bronchiectasis Health Questionnaire
  9. Rasch analysis and impact factor methods both yield valid and comparable measures of health status in interstitial lung disease
  10. TNF-α-Induced NF-κB Activation Stimulates Skeletal Muscle Glycolytic Metabolism Through Activation of HIF-1α
  11. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice
  12. Impaired exercise training-induced muscle fiber hypertrophy and Akt/mTOR pathway activation in hypoxemic patients with COPD
  13. Nutritional advances in patients with respiratory diseases: FIGURE 1
  14. Differential sensitivity of oxidative and glycolytic muscles to hypoxia-induced muscle atrophy
  15. Cigarette Smoke Extract Induces a Phenotypic Shift in Epithelial Cells; Involvement of HIF1α in Mesenchymal Transition
  16. Nutritional assessment and therapy in COPD: a European Respiratory Society statement
  17. Hypoxia differentially regulates muscle oxidative fiber type and metabolism in a HIF-1α-dependent manner
  18. An Official American Thoracic Society/European Respiratory Society Statement: Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
  19. Activation of alternative NF-κB signaling during recovery of disuse-induced loss of muscle oxidative phenotype
  20. The Muscle Oxidative Regulatory Response to Acute Exercise Is Not Impaired in Less Advanced COPD Despite a Decreased Oxidative Phenotype
  21. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression
  22. Dietary fibre and fatty acids in chronic obstructive pulmonary disease risk and progression: a systematic review
  23. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease
  24. Metabolic and Structural Changes in Lower-Limb Skeletal Muscle Following Neuromuscular Electrical Stimulation: A Systematic Review
  25. Reference values for vastus lateralis fiber type proportions and fiber size
  26. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine?
  27. Regulation of skeletal muscle oxidative phenotype by classical NF-κB signalling
  28. Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia
  29. Chronic obstructive pulmonary disease patient journey
  30. Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD
  31. The mechanisms of cachexia underlying muscle dysfunction in COPD
  32. Central Fat and Peripheral Muscle
  33. Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells
  34. Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD
  35. The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease
  36. Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease
  37. Hypoxia and muscle maintenance regulation
  38. Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?
  39. Diabetes and Lung Function: Response
  40. TNF-  impairs regulation of muscle oxidative phenotype: implications for cachexia?
  41. Pulmonary Function in Diabetes
  42. Regulation of mitochondrial biogenesis during myogenesis
  43. The pathophysiology of cachexia in chronic obstructive pulmonary disease
  44. The prevalence of quadriceps weakness in COPD and the relationship with disease severity
  45. Systemic and Pulmonary Oxidative Stress After Single-Leg Exercise in COPD
  46. PPARγ inhibits NF-κB-dependent transcriptional activation in skeletal muscle
  47. Extrapulmonary Manifestations of Chronic Obstructive Pulmonary Disease in a Mouse Model of Chronic Cigarette Smoke Exposure
  48. Quadriceps muscle strength in scoliosis
  49. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles vs. lower limb muscle dysfunction vs. dynamic hyperinflation
  50. Metabolic and functional effects of glutamate intake in patients with chronic obstructive pulmonary disease (COPD)
  51. Fatigued muscles in COPD but no finishing line in sight
  52. Peroxisome proliferator-activated receptors: a therapeutic target in COPD?
  53. "REDUCED MITOCHONDRIAL DENSITY IN THE VASTUS LATERALIS MUSCLE OF PATIENTS WITH COPD". H.R. GOSKER, M.K.C. HESSELINK, H. DUIMEL, K.A. WARD AND A.M.W.J. SCHOLS. EUR RESPIR J 2007; 30: 73 79.
  54. Cytokine profile in quadriceps muscles of patients with severe COPD
  55. A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans
  56. Muscle Metabolic Modulation by Chronic Hypoxia
  57. Systemic Inflammation and Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: State of the Art and Novel Insights in Regulation of Muscle Plasticity
  58. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD
  59. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis
  60. The Functional, Metabolic, and Anabolic Responses to Exercise Training in Renal Transplant and Hemodialysis Patients
  61. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD
  62. Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease
  63. Altered antioxidant status in peripheral skeletal muscle of patients with COPD
  64. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease
  65. Uncoupling protein‐3 content is decreased in peripheral skeletal muscle of patients with COPD
  66. Striking Similarities in Systemic Factors Contributing to Decreased Exercise Capacity in Patients With Severe Chronic Heart Failure or COPD
  67. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease
  68. Muscle metabolic status in patients with severe COPD with and without long-term prednisolone
  69. Inhibition of Preprotein Translocation and Reversion of the Membrane Inserted State of SecA by a Carboxyl Terminus Binding MAb†